Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group

2005491 citationsJournal Article

Authors

This phase III, randomized, multicenter trial showed no difference in survival between patients treated with CF or CP.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 23, Issue 15, pp. 3562-3567

Field-Weighted Citation Impact: 17.19